177 related articles for article (PubMed ID: 33596468)
21. Phenotypic and Genotypic Correlation of Antimicrobial Susceptibility of Bacteroides fragilis: Lessons Learnt.
Jha L; Y BL; Ragupathi NKD; Veeraraghavan B; Prakash JAJ
Cureus; 2023 Mar; 15(3):e36268. PubMed ID: 37073211
[TBL] [Abstract][Full Text] [Related]
22. Antimicrobial susceptibility testing of anaerobic bacteria causing bacteremia: A 13-year (2010-2022) retrospective study in a tertiary hospital.
Ligero-López J; Rubio-Mora E; Ruiz-Bastián MD; Quiles-Melero MI; Cacho-Calvo J; Cendejas-Bueno E
Anaerobe; 2023 Dec; 84():102803. PubMed ID: 37984560
[TBL] [Abstract][Full Text] [Related]
23. Bacteremia caused by Anaerococcus SPP: Is this an underdiagnosed infection?
Cobo F; Pérez-Carrasco V; González A; Sánchez-Martin V; García-Salcedo JA; Navarro-Marí JM
Anaerobe; 2021 Aug; 70():102405. PubMed ID: 34153469
[TBL] [Abstract][Full Text] [Related]
24. Development of EUCAST disk diffusion method for susceptibility testing of the Bacteroides fragilis group isolates.
Nagy E; Justesen US; Eitel Z; Urbán E;
Anaerobe; 2015 Feb; 31():65-71. PubMed ID: 25464140
[TBL] [Abstract][Full Text] [Related]
25. Clinically significant anaerobic bacteria isolated from patients in a South African academic hospital: antimicrobial susceptibility testing.
Naidoo S; Perovic O; Richards GA; Duse AG
S Afr Med J; 2011 Sep; 101(10):732, 734. PubMed ID: 22272862
[TBL] [Abstract][Full Text] [Related]
26. The European committee on antimicrobial susceptibility testing disc diffusion susceptibility testing method for frequently isolated anaerobic bacteria.
Matuschek E; Copsey-Mawer S; Petersson S; Åhman J; Morris TE; Kahlmeter G
Clin Microbiol Infect; 2023 Jun; 29(6):795.e1-795.e7. PubMed ID: 36746258
[TBL] [Abstract][Full Text] [Related]
27. High rate of non-susceptibility to metronidazole and clindamycin in anaerobic isolates: Data from a clinical laboratory from Karachi, Pakistan.
Sheikh SO; Jabeen K; Qaiser S; Ahsan ST; Khan E; Zafar A
Anaerobe; 2015 Jun; 33():132-6. PubMed ID: 25800668
[TBL] [Abstract][Full Text] [Related]
28. Gram negative anaerobe susceptibility testing in clinical isolates using Sensititre and Etest methods.
Hughes C; Ashhurst-Smith C; Ferguson JK
Pathology; 2018 Jun; 50(4):437-441. PubMed ID: 29678480
[TBL] [Abstract][Full Text] [Related]
29. [Antimicrobial Susceptibility Profiles of Prevotella Species Determined by Gradient Test Method in Two Centers in Istanbul].
Ülger Toprak N; Akgül Ö; Külekçi G; Söyletir G
Mikrobiyol Bul; 2020 Apr; 54(2):246-256. PubMed ID: 32723280
[TBL] [Abstract][Full Text] [Related]
30. Bacteremia Caused by the
Jiang J; She B; Zheng R
Infect Drug Resist; 2020; 13():3695-3698. PubMed ID: 33116689
[No Abstract] [Full Text] [Related]
31. Antimicrobial resistance in the Bacteroides fragilis group in faecal samples from patients receiving broad-spectrum antibiotics.
Hansen KCM; Schwensen SAF; Henriksen DP; Justesen US; Sydenham TV
Anaerobe; 2017 Oct; 47():79-85. PubMed ID: 28445776
[TBL] [Abstract][Full Text] [Related]
32. Anaerobic, non-sporulating, Gram-positive bacilli bacteraemia characterized by 16S rRNA gene sequencing.
Lau SK; Woo PC; Fung AM; Chan KM; Woo GK; Yuen KY
J Med Microbiol; 2004 Dec; 53(Pt 12):1247-1253. PubMed ID: 15585505
[TBL] [Abstract][Full Text] [Related]
33. In vitro activity of amoxycillin/clavulanate and ticarcillin/clavulanate compared with that of other antibiotics against anaerobic bacteria: comparison with the results of the 1987 survey.
Pierard D; De Meyer A; Rosseel P; Van Cauwenbergh M; Struelens MJ; Delmee M; Goossens H; Claeys G; Glupczynski Y; Verbist L; Melin P; Lauwers S
Acta Clin Belg; 1996; 51(2):70-9. PubMed ID: 8693871
[TBL] [Abstract][Full Text] [Related]
34. [Identification of anaerobic bacteria isolated from various clinical specimens and determination of antibiotic susceptibilities].
Doğan M; Baysal B
Mikrobiyol Bul; 2010 Apr; 44(2):211-9. PubMed ID: 20549955
[TBL] [Abstract][Full Text] [Related]
35. Antimicrobial susceptibility pattern of bacteria isolated from patients with urinary tract infection.
Khan IU; Mirza IA; Ikram A; Afzal A; Ali S; Hussain A; Fayyaz M; Ghafoor T
J Coll Physicians Surg Pak; 2014 Nov; 24(11):840-4. PubMed ID: 25404444
[TBL] [Abstract][Full Text] [Related]
36. Comparative in vitro activity of Meropenem, Imipenem and Piperacillin/tazobactam against 1071 clinical isolates using 2 different methods: a French multicentre study.
Joly-Guillou ML; Kempf M; Cavallo JD; Chomarat M; Dubreuil L; Maugein J; Muller-Serieys C; Roussel-Delvallez M
BMC Infect Dis; 2010 Mar; 10():72. PubMed ID: 20298555
[TBL] [Abstract][Full Text] [Related]
37. Antimicrobial resistance among anaerobes isolated from clinical specimens in Kuwait hospitals: comparative analysis of 11-year data.
Jamal W; Al Hashem G; Rotimi VO
Anaerobe; 2015 Feb; 31():25-30. PubMed ID: 25193745
[TBL] [Abstract][Full Text] [Related]
38. Antimicrobial susceptibility of Bacteroides fragilis group organisms in Hong Kong by the tentative EUCAST disc diffusion method.
Ho PL; Yau CY; Ho LY; Lai EL; Liu MC; Tse CW; Chow KH
Anaerobe; 2017 Oct; 47():51-56. PubMed ID: 28414107
[TBL] [Abstract][Full Text] [Related]
39. Antimicrobial susceptibility among gram-positive and gram-negative blood-borne pathogens collected between 2012-2016 as part of the Tigecycline Evaluation and Surveillance Trial.
Zhang Z; Chen M; Yu Y; Pan S; Liu Y
Antimicrob Resist Infect Control; 2018; 7():152. PubMed ID: 30564308
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of VITEK MS, Clin-ToF-II MS, Autof MS 1000 and VITEK 2 ANC card for identification of Bacteroides fragilis group isolates and antimicrobial susceptibilities of these isolates in a Chinese university hospital.
Wang Y; Chen XF; Xie XL; Xiao M; Yang Y; Zhang G; Zhang JJ; Duan SM; Zhang Q; Zhang P; Tsui C; Xu YC
J Microbiol Immunol Infect; 2019 Jun; 52(3):456-464. PubMed ID: 30772212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
